Literature DB >> 19949673

Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma.

Won Tae Kim1, Won Sik Ham, Hee Jeong Ju, Jin Sun Lee, Jin Sung Lee, Young Deuk Choi.   

Abstract

This study was done to analyze the clinical characteristics of renal cell carcinoma (RCC) in Korean patients with von Hippel-Lindau (VHL) disease. Between January 1996 and July 2008, 1,514 patients were diagnosed with RCC and 24 patients were diagnosed with VHL disease at our institute. We analyzed the clinical characteristics of the 24 patients diagnosed with VHL. The mean age of patients with VHL was 39.2+/-12.6 yr; the mean age of patients with both VHL and RCC was 42.5+/-10.3 yr. Among the 24 patients with VHL, 7 patients had retinal angiomas, 11 had RCC, 16 had renal lesions, 18 had pancreatic lesions and 21 had cerebellar hemangioblastomas. There was no significant difference between survival rates of patients with VHL alone and those with VHL and RCC. However, cancer-specific survival rates were significantly different between patients with both VHL and RCC and patients with sporadic bilateral or multifocal RCC. In our Korean study, the incidence of RCC in patients with VHL disease is 45.8% and the incidence of VHL disease in patients with RCC is 0.73%. Due to the low overall incidence of VHL in Korea, extended multi-institutional studies are needed to establish the true characteristics of VHL disease.

Entities:  

Keywords:  Carcinoma, Renal Cell; Incidence; Von Hippel-Lindau Disease

Mesh:

Year:  2009        PMID: 19949673      PMCID: PMC2775865          DOI: 10.3346/jkms.2009.24.6.1145

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  18 in total

1.  DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.

Authors:  B Klein; G Weirich; H Brauch
Journal:  Hum Genet       Date:  2001-05       Impact factor: 4.132

Review 2.  Von Hippel-Lindau syndrome. A pleomorphic condition.

Authors:  C A Friedrich
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

3.  A genetic register for von Hippel-Lindau disease.

Authors:  I R Maddock; A Moran; E R Maher; M D Teare; A Norman; S J Payne; R Whitehouse; C Dodd; M Lavin; N Hartley; M Super; D G Evans
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

4.  Management of renal cell carcinoma in von Hippel-Lindau disease.

Authors:  F J Hes; P J Slootweg; T J van Vroonhoven; R J Hené; M A Feldberg; R A Zewald; J K Ploos van Amstel; J W Höppener; P L Pearson; C J Lips
Journal:  Eur J Clin Invest       Date:  1999-01       Impact factor: 4.686

Review 5.  Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group.

Authors:  S Richard; C Campello; L Taillandier; F Parker; F Resche
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

Review 6.  Molecular genetic analysis of von Hippel-Lindau disease.

Authors:  F M Richards; A R Webster; R McMahon; E R Woodward; S Rose; E R Maher
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

7.  Parenchymal sparing surgery in patients with hereditary renal cell carcinoma.

Authors:  M M Walther; P L Choyke; G Weiss; C Manolatos; J Long; R Reiter; R B Alexander; W M Linehan
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

8.  Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Authors:  F Chen; T Kishida; M Yao; T Hustad; D Glavac; M Dean; J R Gnarra; M L Orcutt; F M Duh; G Glenn
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

9.  Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.

Authors:  Guillaume Ploussard; Stéphane Droupy; Sophie Ferlicot; Racula Ples; Laurence Rocher; Stéphane Richard; Gérard Benoit
Journal:  Urology       Date:  2007-09       Impact factor: 2.649

10.  Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma.

Authors:  H P Neumann; B U Bender; D P Berger; J Laubenberger; W Schultze-Seemann; U Wetterauer; F J Ferstl; E W Herbst; G Schwarzkopf; F J Hes; C J Lips; J M Lamiell; O Masek; P Riegler; B Mueller; D Glavac; H Brauch
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

View more
  7 in total

1.  Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.

Authors:  Taekmin Kwon; In Gab Jeong; Sahyun Pak; Dalsan You; Cheryn Song; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

2.  Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.

Authors:  Allison B Weisbrod; Mio Kitano; Krisana Gesuwan; Corina Millo; Peter Herscovitch; Naris Nilubol; W Marston Linehan; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2012-01-18       Impact factor: 5.958

3.  Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.

Authors:  Sena Hwang; Cheol Ryong Ku; Ji In Lee; Kyu Yeon Hur; Myung-Shik Lee; Chul-Ho Lee; Kyo Yeon Koo; Jin-Sung Lee; Yumie Rhee
Journal:  J Hum Genet       Date:  2014-07-31       Impact factor: 3.172

4.  A novel mutation in the von hippel-lindau tumor suppressor gene identified in a patient presenting with gestational diabetes mellitus.

Authors:  Yun Hyi Ku; Chang Ho Ahn; Chan-Hyeon Jung; Jie Eun Lee; Lee-Kyung Kim; Soo Heon Kwak; Hye Seung Jung; Kyong Soo Park; Young Min Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2013-12-12

5.  Hemangioblastoma Instead of Renal Cell Carcinoma Plays a Major Role in the Unfavorable Overall Survival of Von Hippel-Lindau Disease Patients.

Authors:  Bowen Zhou; Jiangyi Wang; Shengjie Liu; Xiang Peng; Baoan Hong; Jingcheng Zhou; Kaifang Ma; Jiufeng Zhang; Lin Cai; Kan Gong
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

Review 6.  Heritable Cancer Syndromes Related to the Hypoxia Pathway.

Authors:  John Clark Henegan; Christian R Gomez
Journal:  Front Oncol       Date:  2016-03-22       Impact factor: 6.244

7.  Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.

Authors:  Patrick Schuhmacher; Emily Kim; Felix Hahn; Peggy Sekula; Cordula Annette Jilg; Christian Leiber; Hartmut P Neumann; Wolfgang Schultze-Seemann; Gerd Walz; Stefan Zschiedrich
Journal:  Orphanet J Rare Dis       Date:  2019-10-28       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.